Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceSTAARVISC II
Generic NameAID, SURGICAL, VISCOELASTIC
Regulation Number886.4275
ApplicantAnika Therapeutics, Inc.
32 WIGGINS AVENUE
BEDFORD, MA 01730
PMA NumberP000046
Date Received11/06/2000
Decision Date04/18/2001
Product Code LZP 
Docket Number 01M-0227
Notice Date 05/14/2001
Advisory Committee Ophthalmic
Expedited Review Granted? No
Combination ProductNo
RecallsCDRH Recalls
Approval Order Statement  
APPROVAL FOR REFERENCE RIGHTS TO P810025, AND FOR STAAR SURGICAL COMPANY TO DISTRIBUTE THE SODIUM HYALURONATE UNDER THE TRADENAME STAARVISC(TM) II. THE DEVICE IS INDICATED FOR USE DURING SURGERY IN THE ANTERIOR AND POSTERIOR SEGMENTS OF THE HUMAN EYE. PROCEDURES INCLUDE: CATARACT EXTRACTION, INTRAOCULAR LENS (IOL) IMPLANTATION, CORNEAL TRANSPLANTATION SURGERY, GLAUCOMA FILTERING SURGERY AND SURGICAL PROCEDURES TO REATTACH THE RETINA. STAARVISC9TM) II IS DESIGNED TO CREATE AND MAINTAIN ANTERIOR CHAMBER DEPTH AND VISIBILITY, PROTECT CORNEAL ENDOTHELIAL CELLS AND OTHER INTRAOCULAR TISSUES, MINIMIZE INTERATION BETWEEN TISSUES DURING SURGICAL MANIPULATION, AND ACT AS A VITREOUS SUBSTITUTE DURING RETINAL REATTACHMENT SURGERY. STAARVISC(TM) II ALSO PRESERVES TISSUE INTEGRITY AND GOOD VISIBILITY WHEN USED TO FILL THE ANTERIOR AND POSTERIOR SEGMENTS OF THE EYE FOLLOWING OPEN SKY PROCEDURES.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Supplements:  S001 S002 S003 S004 S006 S007 S008 S009 S010 S011 S012 
S013 S014 S015 S016 S017 S018 S019 S020 S021 S022 S023 S024 
S025 S026 S027 S028 S029 S030 
-
-